Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study

(2014) L Ban et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Effects of perinatal mental disorders on the fetus and child

(2014) Alan Stein et al.   LANCET

Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period

(2014) Ian Jones et al.   LANCET

Antidepressant Use in Pregnancy and the Risk of Cardiac Defects

(2014) Krista F. Huybrechts et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validity of maternal and infant outcomes within nationwide Medicaid data

(2014) Kristin Palmsten et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations

(2013) Nicholas Myles et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations

(2013) Svetlana Skurtveit et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Antidepressant Exposure During Pregnancy and Congenital Malformations: Is There an Association?

(2013) Sophie Grigoriadis et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antidepressant Use During Early Pregnancy and the Risk of Congenital Anomalies

(2013) Catherine Vasilakis-Scaramozza et al.   PHARMACOTHERAPY

Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression

(2012) Hedvig Nordeng et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Selective serotonin reuptake inhibitors and malformations: Case closed?

(2012) Gideon Koren et al.   Seminars in Fetal & Neonatal Medicine

Paper 6: EUROCAT member registries: Organization and activities

(2011) Ruth Greenlees et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Paper 1: The EUROCAT network-organization and processes†

(2011) Patricia A. Boyd et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Paper 5: Surveillance of multiple congenital anomalies: Implementation of a computer algorithm in European registers for classification of cases

(2011) Ester Garne et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy

(2011) Lyn Colvin et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Congenital Heart Defects in Europe

(2011) Helen Dolk et al.   CIRCULATION

Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls

(2011) A. Hackshaw et al.   HUMAN REPRODUCTION UPDATE

Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study

(2011) Chagit Klieger-Grossmann et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pregnancy as a Major Determinant for Discontinuation of Antidepressants

(2011) Irene Petersen et al.   JOURNAL OF CLINICAL PSYCHIATRY

Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies

(2011) Heli Malm et al.   OBSTETRICS AND GYNECOLOGY

Selective serotonin reuptake inhibitors (SSRIs) and heart defects: Potential mechanisms for the observed associations

(2011) T.W. Sadler   REPRODUCTIVE TOXICOLOGY

Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations

(2010) Janneke Jentink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

(2010) M. Reis et al.   PSYCHOLOGICAL MEDICINE

Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis

(2010) Kornum   Clinical Epidemiology

First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: A meta-analysis of epidemiological studies

(2009) Keele E. Wurst et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur

(2009) Paul Merlob et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Maternal Overweight and Obesity and the Risk of Congenital Anomalies

(2009) Katherine J. Stothard et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluation of the Risk of Congenital Cardiovascular Defects Associated With Use of Paroxetine During Pregnancy

(2008) Adrienne Einarson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Use of specified critical periods of different congenital abnormalities instead of the first trimester concept

(2008) Andrew E. Czeizel et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands

(2007) Marian K. Bakker et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY